败血症新生儿血栓调节蛋白和D-二聚体的变化及意义

郝玲,王娜

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (10) : 841-844.

PDF(1236 KB)
PDF(1236 KB)
中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (10) : 841-844. DOI: 10.7499/j.issn.1008-8830.2013.10.008
论著·临床研究

败血症新生儿血栓调节蛋白和D-二聚体的变化及意义

  • 郝玲,王娜
作者信息 +

Changes in plasma thrombomodulin and D-dimer levels and their clinical significance in neonates with sepsis

  • HAO Ling, WANG Na
Author information +
文章历史 +

摘要

目的:观察败血症新生儿血栓调节蛋白(TM)和D-二聚体(DD)的变化,探讨二者在败血症新生儿病情评估及预后判断中的意义。方法:将56例败血症新生儿进行新生儿危重病例评分,分为极危重组(13例)、危重组(22例)和非危重组(21例),在入院初期及恢复期采空腹静脉血,应用酶联免疫吸附试验测定血浆TM,应用免疫比浊法测定血浆DD。26例健康新生儿作为对照组。比较各组血浆TM和DD的差异及败血症新生儿治疗前后二者的变化。结果:败血症极危重组、危重组、非危重组新生儿血浆TM水平分别为25.5±6.6、17.3±4.7、13.3±2.8 μg/L,较对照组的9.8±2.7 μg/L明显升高(P<0.01)。败血症极危重组、危重组新生儿血浆DD水平分别为744±262、436±147 μg/L,较对照组的205±61 μg/L明显升高(P<0.01)。非危重组、危重组、极危重组3组血浆TM和DD水平依次升高(P<0.05)。治疗后(恢复期)患儿血浆TM和DD水平显著下降,与治疗前比较差异有统计学意义(P<0.01)。血浆TM和DD水平与新生儿危重评分均呈明显负相关(分别r=-0.428、-0.363,P<0.01)。结论:检测败血症新生儿的血浆TM和DD水平有助于评估病情危重程度及预后。

Abstract

OBCTIVE: To observe changes in plasma thrombomodulin (TM) and D-dimer (DD) levels in neonates with sepsis, and to investigate their significance in evaluating the patients' condition and prognosis. METHOD: Fifty-six neonates with sepsis were classified into extremely critical (n=13), critical (n=22) and non-critical groups (n=21) based on neonatal critical illness score (NCIS). Fasting venous blood samples were collected on admission and in the recovery phase. Plasma TM and D-dimer levels were measured using enzyme-linked immunosorbent assay and immune turbidimetry, respectively. Twenty-six healthy neonates were selected as the control group. Plasma TM and D-dimer levels were compared between groups, and the changes after treatment were determined. RESULTS: Plasma TM levels in the extremely critical, critical and non-critical groups were 25.5±6.6, 17.3±4.7 and 13.3±2.8 μg/L respectively, significantly higher than in the control group (9.8±2.7 μg/L) (P<0.01). Plasma D-dimer levels in the extremely critical and critical groups were 744±262 and 436±147 μg/L respectively, also significantly higher than in the control group (205±61 μg/L) (P<0.01). The extremely critical group had significantly higher plasma TM and DD levels than the critical group (P<0.05), and the critical group had significantly higher plasma TM and DD levels than the non-critical group (P<0.05). All patients showed significant decreases in plasma TM and DD levels in the recovery phase after treatment (P<0.01). Plasma TM and DD levels were significantly negatively correlated with NCIS (r?=?-0.428, P<0.01; r?=?-0.363, P<0.01). CONCLUSIONS: Determination of plasma TM and DD levels may be helpful in evaluating severity and prognosis in neonates with sepsis.

关键词

败血症 / 血栓调节蛋白 / D-二聚体 / 新生儿

Key words

Sepsis / Thrombomodulin / D-dimer / Neonate

引用本文

导出引用
郝玲,王娜. 败血症新生儿血栓调节蛋白和D-二聚体的变化及意义[J]. 中国当代儿科杂志. 2013, 15(10): 841-844 https://doi.org/10.7499/j.issn.1008-8830.2013.10.008
HAO Ling, WANG Na. Changes in plasma thrombomodulin and D-dimer levels and their clinical significance in neonates with sepsis[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(10): 841-844 https://doi.org/10.7499/j.issn.1008-8830.2013.10.008

参考文献

[1] 王平, 曾晓辉, 唐莲. 急性感染患儿危重病例评分与凝血功能紊乱的关系[J]. 临床儿科杂志, 2009, 27(6): 521-523.

[2] 中华医学会儿科学分会新生儿学组. 新生儿败血症诊疗方案[J]. 中华儿科杂志, 2003, 41(12): 897-899.

[3] 中华医学会急诊学分会儿科学组, 中华医学会儿科学分会急诊学组, 新生儿学组. 新生儿危重病例评分法(草案)[J]. 中华儿科杂志, 2001, 39(1): 42-43.

[4] 姜毅. 新生儿败血症诊疗进展[J]. 中国新生儿科杂志, 2010, 25(2): 69-72.

[5] 王政力, 余加林. 新生儿败血症诊断新进展[J].中国当代儿科杂志, 2013, 15(3): 236-241.

[6] 李世芳, 赵淑艳, 马晓花, 张环. 危重新生儿凝血指标与危重评分的临床分析[J].中国当代医药, 2012, 19(14): 89-90.

[7] Kaneko T, Wada H. Diagnositic criteria and laboratory tests for disseminated intravascular coagulation[J]. J Din Exp Hematop, 2011, 51(2): 67-76.

[8] Conway EM. Thrombomodulin and its role in inflammation[J]. Semin Immunopathol, 2012, 34(1): 107-125.

[9] Lin SM, Wang YM, Lin HC, Lee KY, Huang CD, Liu CY, et al. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis[J]. Crit Care Med, 2008, 36(3): 683-689.

[10] 李颖, 曲东, 李杰. 低分子肝素改善脓毒症凝血功能临床疗效观察[J].中国实用儿科杂志, 2010, 25(6): 453-455.

[11] Levi M, Van der Poll T. Thrombomodulin in sepsis[J]. Minerva Anestesiol, 2012, 79(3): 294-298.

[12] 李丹丹, 马聪. D二聚体检测的临床应用进展[J]. 血栓与止血学, 2011, 17(3): 138-144.

[13] 孙乐科, 万建华, 徐建强. 新生儿窒息早产患儿凝血功能改变[J]. 实用临床医学, 2011, 12(8): 83-86.

[14] 武万良, 李凤侠, 向磊. 脓毒血症患儿的凝血功能检测[J]. 临床儿科杂志, 2010, 28(1): 24-33.

[15] 王凡, 徐丁, 豆莉, 韩亚梅. 新生儿出生第1天凝血指标与危重评分相关性研究[J]. 中国新生儿科杂志, 2011, 26(4): 242-244.


PDF(1236 KB)

Accesses

Citation

Detail

段落导航
相关文章

/